Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Lava Therapeutics
With
This trial is an open-label Phase 1 dose escalation trial with an expansion cohort to investigate the safety and tolerability of LAVA-1207 alone or with low dose interleukin-2 or Pembrolizumab, in patients with therapy refractory mCRPC. The trial was intended to be a Phase 1/2 trial (but the trial never moved forward to Phase 2).
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted